|
Treating oft ignored non-cancer health issues after cancer diagnosis prolongs survival
December 28, 2007INDIANAPOLIS -Receiving treatment for non-cancer health issues while being treated by specialists for cancer improves cancer survival rates according to a study published in the December 20 issue of the Journal of Clinical Oncology.
The study, by researchers from the Indiana University School of Medicine, the Regenstrief Institute and the Roudebush Veterans Administration Medical Center, is the first to look at the effect of primary care on health outcomes in cancer patients.
Receiving care from a primary care physician (a general internist or family practice doctor) during cancer treatment from an oncologist appears to improve cancer survival rates, likely due to the comprehensiveness of care that is received in primary care, according to study authors Caroline Carney Doebbeling, M.D., M.Sc. and Laura Jones, Ph.D. The researchers focused on lung cancer because of the low one-year lung cancer survival rate in these patients.
"We cannot afford to ignore the chronic medical conditions that most cancer patients have because treating these conditions may bring increased longevity as well as improved quality of life. Lung cancer patients are often faced with many additional health issues, such as high blood pressure, emphysema and other respiratory conditions, all of which can and should be treated," said Dr. Carney Doebbeling, associate professor of medicine and of psychiatry at the Indiana University School of Medicine and a Regenstrief Institute research scientist.
"When doctors think their patients have a higher risk of mortality, as they do with lung cancer, chronic disease management may be not as big a focus," said Dr. Jones, who is with the Roudebush VA Medical Center's Center of Excellence on Implementing Evidence-Based Practice and is a health services researcher.
Lack of primary care utilization in the first six months following lung cancer diagnosis had a marked effect on survival even when controlling for extent of the disease. The researchers looked at electronic medical record data of 323 male veterans diagnosed with lung cancer. The median survival rate was only 3.68 months for those without primary care utilization, but increased by a factor of more than four if the patient had at least 3 primary care visits during the first 6 months following cancer diagnosis.
"Further investigation is needed to gain a better understanding of how and why primary care utilization improved outcomes in lung cancer patients. What we do know is that over 80 percent of lung cancer patients have at least one additional serious medical condition. The take home message to cancer patients is to not stop seeing your primary care doctor even if you have cancer," said Dr. Carney Doebbeling. "The importance of managing the health of the whole person, not just one disease at a time, cannot be overstated."
Indiana University
"We cannot afford to ignore the chronic medical conditions that most cancer patients have because treating these conditions may bring increased longevity as well as improved quality of life. Lung cancer patients are often faced with many additional health issues, such as high blood pressure, emphysema and other respiratory conditions, all of which can and should be treated," said Dr. Carney Doebbeling, associate professor of medicine and of psychiatry at the Indiana University School of Medicine and a Regenstrief Institute research scientist.
"When doctors think their patients have a higher risk of mortality, as they do with lung cancer, chronic disease management may be not as big a focus," said Dr. Jones, who is with the Roudebush VA Medical Center's Center of Excellence on Implementing Evidence-Based Practice and is a health services researcher.
Lack of primary care utilization in the first six months following lung cancer diagnosis had a marked effect on survival even when controlling for extent of the disease. The researchers looked at electronic medical record data of 323 male veterans diagnosed with lung cancer. The median survival rate was only 3.68 months for those without primary care utilization, but increased by a factor of more than four if the patient had at least 3 primary care visits during the first 6 months following cancer diagnosis.
"Further investigation is needed to gain a better understanding of how and why primary care utilization improved outcomes in lung cancer patients. What we do know is that over 80 percent of lung cancer patients have at least one additional serious medical condition. The take home message to cancer patients is to not stop seeing your primary care doctor even if you have cancer," said Dr. Carney Doebbeling. "The importance of managing the health of the whole person, not just one disease at a time, cannot be overstated."
Indiana University
Lung Cancer News and Current Lung Cancer Events RSSNew oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
Faulty DNA repair could be a risk factor for lung cancer in nonsmokers
People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at higher risk of developing lung cancer than those with effective genomic repair capability.
Ability to track stem cells in tumors could advance cancer treatments
Using noninvasive molecular imaging technology, a method has been developed to track the location and activity of mesenchymal stem cells (MSCs) in the tumors of living organisms.
CT lung cancer screening no cure-all for smokers
Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current and former smokers, but it won't protect them from other causes of death associated with smoking, according to a new study published in the July issue of the journal Radiology.
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers.
Gene therapy increases survival for end-stage head and neck cancer
A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston.
A new way to look at lung cancer and tobacco carcinogens
Two types of cancer-causing agents in cigarettes-a nicotine-derived chemical and polycyclic aromatic hydrocarbons (PAHs) are the main culprits in lung cancer. Exposure to tobacco smoke - both mainstream and second-hand - is a leading cause of cancer death in the United States.
Fruits, vegetables and teas may protect smokers from lung cancer, UCLA researchers report
Tobacco smokers who eat three servings of fruits and vegetables per day and drink green or black tea may be protecting themselves from lung cancer, according to a first-of-its-kind study by UCLA cancer researchers.
Genetic mutation associated with increased risk of lung cancer
Carriers of a common genetic disorder previously linked to lung disease may have a 70-percent to 100-percent increased risk of lung cancer, according to a report in the May 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Determining genetic signature of lung tumors can help guide treatment
The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line treatment rather than after standard chemotherapy has failed.
More Lung Cancer News Articles
 | How to Survive Lung Cancer - A Practical 12-Step Plan by Michael Lloyd |
 | Surviving Cancer by Margie Levine |
 | Lung Cancer: Myths, Facts, Choices--and Hope by Claudia I. Henschke, Peggy McCarthy, Sarah Wernick |
 | 100 Questions & Answers About Lung Cancer (100 Questions & Answers about . . .) by Karen Parles, Joan H. Schiller |
 | Lung Cancer: Dana-Farber Cancer Institute Handbook (Dana-Farber Cancer Institute Handbooks) |
 | Voices of Lung Cancer: The Healing Companion: Stories for Courage, Comfort and Strength (Voices Of series) |
 | What to Eat if You Have Cancer by Daniella Chace, Maureen Keane, John A. Lung |
 | High-Resolution CT of the Lung by W. Richard Webb, Nestor L Müller, David P Naidich |
 | Lung Cancer: Making Sense of Diagnosis, Treatment, and Options by Lorraine Johnston |
 | Image-Guided Radiotherapy of Lung Cancer |
| © 2008 BrightSurf.com |